Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 41

Trial Status

Completed18
Terminated1
Other15

Role Distribution

Principal Investigator34
PI Rate100%

Activity Timeline

Clinical Trials (20)

NCT07192159Not ApplicableActive Not Recruiting
Quantitative Ultrasound (RS85 and R20) for Liver Fat Quantification in MASLD Using MRI-PDFF as Reference
Hepatic SteatosisLiver Disease ParenchymalMetabolic Dysfunction-Associated Steatotic Liver Disease
PrincipalinvestigatorStart date: 2025-06-24
NCT05790590Not ApplicableUnknown
Comparison of Image Quality Between "Double Low Dose" Liver CT and Standard Liver CT
Colorectal CancerMetastasis to Liver
PrincipalinvestigatorStart date: 2023-05-30
Comparison Between LDCT With DL Recontruction and Standard Dose CT
Liver Metastases
PrincipalinvestigatorStart date: 2022-06-02
NCT05182099Not ApplicableUnknown
High Resolution HBA-MRI Using Deep Learning Reconstruction
Deep LearningLiver DiseasesMagnetic Resonance Imaging
PrincipalinvestigatorStart date: 2022-01-10
NCT04195971Not ApplicableUnknown
Dual Arterial Phase Liver CT in Patients With Suspected Portal Hypertension
Cirrhosis, LiverHCC
PrincipalinvestigatorStart date: 2019-12-26
NCT04024514Not ApplicableUnknown
Renal Protocol Protection in CKD Patients
CKDHCC
PrincipalinvestigatorStart date: 2019-12-24
NCT04027556Not ApplicableCompleted
Low-contrast Dose Liver CT Using Lean Body Weight Low Monoenergetic Images and Deep Learning-based Reconstruction
Body WeightCarcinoma, Hepatocellular
PrincipalinvestigatorStart date: 2019-06-27
NCT04803890Not ApplicableTerminated
"No-Touch" Radiofrequency Ablation for Small Hepatocellular Carcinoma (≤ 3cm): A Prospective Multicenter Study
Microwave AblationRadiofrequency Ablation
PrincipalinvestigatorStart date: 2019-04-01
NCT03895177Not ApplicableUnknown
Evaluation of Resectability of Pancreatic Cancer Using Low kVp CT
Diagnoses Disease
PrincipalinvestigatorStart date: 2019-03-12
NCT03731910Not ApplicableUnknown
Short-term MRI for Treatment Response Evaluation/Prediction of HCC Treated With TARE
Hepatocellular Carcinoma
PrincipalinvestigatorStart date: 2018-12-11

Showing 10 of 20 trials

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Richard Gary Barr, MD

Northeastern Ohio Radiology Research and Education Fund

Moderately Similar
1 trials

Shared therapeutic areas:

Fatty LiverLiver Disease ParenchymalMetabolic Dysfunction-associated Steatotic Liver Disease

Worked with same sponsors:

Northeastern Ohio Radiology Research and Education FundSeoul National University Hospital
Collaborated on 1 trial
Similarity Score34%

Saleh K Saleh, MD

Minia University

Related
23 trials

Shared therapeutic areas:

Cancer of PancreasCarcinoma, HepatocellularCholangiocarcinoma+2 more
Similarity Score5%

Ajay Goel, PhD

City of Hope Medical Center

Related
24 trials

Shared therapeutic areas:

Colorectal CancerCholangiocarcinomaCancer of Liver+2 more
Similarity Score5%

Eric Bellissant, MD, PhD

Rennes University Hospital

Related
26 trials

Shared therapeutic areas:

Carcinoma, HepatocellularCirrhosisColorectal Cancer+2 more
Similarity Score5%

Tim F Greten, M.D.

National Cancer Institute (NCI)

Related
22 trials

Shared therapeutic areas:

Carcinoma, HepatocellularCancer of LiverColorectal Cancer+2 more
Similarity Score5%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Cancer of LiverNeoplasm MetastasisCancer of Pancreas+1 more

Worked with same sponsors:

Shenzhen Second People's Hospital
Similarity Score4%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Cancer of LiverCarcinoma, HepatocellularCancer of Pancreas+1 more
Similarity Score4%

Xiaolong Qi, MD

LanZhou University

Related
8 trials

Shared therapeutic areas:

Liver CirrhosisCirrhosisLiver Diseases
Similarity Score3%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Cancer of PancreasCancer of LiverColorectal Cancer
Similarity Score3%

Steven A. Rosenberg, MD, PhD

NCI - Surgery Branch

Related
29 trials

Shared therapeutic areas:

Cancer of PancreasColorectal CancerCancer of Liver
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (34)

Showing 20 of 34 trials

NCT07192159Not ApplicablePrincipalInvestigator

Quantitative Ultrasound (RS85 and R20) for Liver Fat Quantification in MASLD Using MRI-PDFF as Reference

Hepatic SteatosisLiver Disease ParenchymalMetabolic Dysfunction-Associated Steatotic Liver Disease
Active Not Recruiting
NCT05790590Not ApplicablePrincipalInvestigator

Comparison of Image Quality Between "Double Low Dose" Liver CT and Standard Liver CT

Colorectal CancerMetastasis to Liver
Unknown
NCT05324046PrincipalInvestigator

Comparison Between LDCT With DL Recontruction and Standard Dose CT

Liver Metastases
Unknown
NCT05182099Not ApplicablePrincipalInvestigator

High Resolution HBA-MRI Using Deep Learning Reconstruction

Deep LearningLiver DiseasesMagnetic Resonance Imaging
Unknown
NCT04195971Not ApplicablePrincipalInvestigator

Dual Arterial Phase Liver CT in Patients With Suspected Portal Hypertension

Cirrhosis, LiverHCC
Unknown
NCT04024514Not ApplicablePrincipalInvestigator

Renal Protocol Protection in CKD Patients

CKDHCC
Unknown
NCT04027556Not ApplicablePrincipalInvestigator

Low-contrast Dose Liver CT Using Lean Body Weight Low Monoenergetic Images and Deep Learning-based Reconstruction

Body WeightCarcinoma, Hepatocellular
Completed
NCT04803890Not ApplicablePrincipalInvestigator

"No-Touch" Radiofrequency Ablation for Small Hepatocellular Carcinoma (≤ 3cm): A Prospective Multicenter Study

Microwave AblationRadiofrequency Ablation
Terminated
NCT03895177Not ApplicablePrincipalInvestigator

Evaluation of Resectability of Pancreatic Cancer Using Low kVp CT

Diagnoses Disease
Unknown
NCT03731910Not ApplicablePrincipalInvestigator

Short-term MRI for Treatment Response Evaluation/Prediction of HCC Treated With TARE

Hepatocellular Carcinoma
Unknown
NCT03731923Not ApplicablePrincipalInvestigator

Abbreviated MRI for HCC Surveillance

Chronic HepatitisHepatocellular CarcinomaLiver Cirrhosis
Unknown
NCT03742453Not ApplicablePrincipalInvestigator

Evaluation of Diagnostic Accuracy of CEUS for HCC Diagnosis

Hepatocellular Carcinoma
Unknown
NCT03045445Not ApplicablePrincipalInvestigator

"Double Low-Dose" DECT for HCC Imaging

HCC
Completed
NCT03085342Not ApplicablePrincipalInvestigator

Evaluation of Hepatic Fibrosis on Multiparametric MRI

CirrhosisHepatitis
Unknown
NCT02944006PrincipalInvestigator

Establishment of Radiomics Database by Clinical Application of Multiparametric MRI Based on Incoherent Undersampling

Pancreas Cancer
Unknown
NCT02832882Not ApplicablePrincipalInvestigator

RFA for Small HCC With No-touch Technique Using Octopus Electrode

Carcinoma, Hepatocellular
Completed
NCT02854371Phase 4PrincipalInvestigator

Evaluation of Hepatic Function Using Gadoxetic Acid Enhanced MRI

Cirrhosis
Completed
NCT02806076Not ApplicablePrincipalInvestigator

RFA for Small HCC With No-touch Technique and Dual Cooled-Wet Electrode

Carcinoma, Hepatocellular
Unknown
NCT02854241Not ApplicablePrincipalInvestigator

Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging for HCC Surveillance

CirrhosisHepatocellular Carcinoma
Unknown
NCT04722120Not ApplicablePrincipalInvestigator

Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC

Hepatocellular Carcinoma
Completed